HealthTech
eGenesis
eGenesis raises $191M Series D
$191M
Total Raised
Series D
Latest Round
2015
Founded
200+
Employees
Cambridge, MA
1 min read
Quick Facts
Latest Round Size
$191M
Latest Round Date
August 2025
eGenesis: Series D Funding Round
eGenesis has successfully raised $191M in Series D funding.
Company Overview
Biotech company developing human-compatible engineered organs through xenotransplantation
Funding Details
The Series D round was led by Lux Capital.
Company Information
- Headquarters: Cambridge, MA
- Founded: 2015
- Employees: 200+
- Category: HealthTech
Investment
eGenesis plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Lux Capital: Verified investor in Series D
Key Investors
Lux Capital
Lead Investor
Verified investor in Series D
About the Author

Editorial Team
Curated funding news from verified sources
Related Company Reports
HealthTech
AccelerateStack Platform
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.

Michael Rodriguez
Oct 8, 2025
3 min read•$75M
HealthTech
DermaSensor
DermaSensor raises $16M Series B at $85M valuation
DermaSensor raises $16M in Series B at $85M valuation. AI-powered skin cancer screening device for early detection...

Editorial Team
Oct 6, 2025
1 min read•$16M
HealthTech
Devoted Health Partners
Devoted Health Partners Headquarters - Office Location & Address
Discover Devoted Health Partners's headquarters at 100 2nd Ave, Waltham, MA 02451. Medicare Advantage insurance. Learn about the office facilities and work environment.

Editorial Team
Oct 5, 2025
2 min read